O'CONNELL JOSEPH P (Chief Medical Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/17/2021ACC: 0001209191-21-011243
Officer· Chief Medical Officer
Since Jun 2018
+152.00
Net shares
Net buyer
$1.6K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
152.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+76.00
Price / share
$21.19
Trade value
$1.61K
% of position
2.3%
2/12/2021
3.35K→3.42K
Total
Net shares
+76.00
Net value
$1.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/12/2021 | A · Award | +76.00 | $21.19 | $1.61K | 2.3% | 3.35K | 3.42K |
| Total | +76.00 | $1.61K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
76.00 shares
Shares
+76.00
Strike price
24.93
Held after
76.00
Exercisable
—
2/12/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock76.00 shares | 2/12/2021 | A · Award | +76.00 | 24.93 | — | 76.00 |